Position in ANVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,901
-$26,128 QoQ
Shares Held
11,775
-45.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 61 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Derivatives in ANVS
reported options exposure · as of Jun 30, 2024CallValue
$144,000
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. ANVS ranks #422 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ANVS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,901 | 11,775 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $48,029 | 21,538 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $106,023 | 30,643 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,310 | 633 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $57,106 | 26,317 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $241,313 | 160,876 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $245,140 | 48,736 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,885 | 1,847 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $74,822 | 12,990 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $144,000 | 25,000 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $7,140 | 600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,220 | 600 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $949 | 100 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,429 | 100 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $4,694 | 414 | Shares | Sole | 2022-08-10 | |
| 2021-12-31 | $43,615 | 2,481 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,477 | 393 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $99,957 | 1,168 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||